The Competition Board concluded the preliminary inquiry conducted about the claim that undertakings operating in the cosmetics, personal care and food supplements industry with direct sale method have violated the Article 4 of the Act no 4054 by determining the resale prices of the resellers and/or restricting their online sales.

After discussing the information and documents acquired and observations made in the preliminary inquiry in its meeting on 17.08.2023, the Board considered the findings significant and sufficient and decided to open an investigation

• with the decision no 2339/734-M(1) to determine whether Amway Türkiye Ltd. (Headquarters in Delaware, USA) Izmir Branch has violated article 4 of the Act no 4054 by determining the resale prices of its resellers and/or restricting their online sales

• with the decision no 2339/734-M(2) to determine whether Ersağ Organizasyon Temizlik Kozmetik Ürünleri Pazarlama Sanayi ve Ticaret Limited Şirketi has violated article 4 of the Act no 4054 by determining the resale prices of its resellers and/or restricting their online sales 

• with the decision no 2339/734-M(3) to determine whether Hunca Life Kozmetik Pazarlama Dağıtım Ticaret Anonim Şirketi has violated Article 4 of the Act no 4054 by determining the resale prices of its resellers and/or restricting their online sales

• with the decision no 2339/734-M(4) to determine whether Oriflame Kozmetik Ürünleri Ticaret Limited Şirketi has violated article 4 of the Act no 4054 by determining the resale prices of its resellers and/or restricting their online sales

• with the decision no 2339/734-M(5) to determine whether Tiens İç ve Dış Ticaret Limited Şirketi has violated article 4 of the Act no 4054 by determining the resale prices of its resellers and/or restricting their online sales

 *Investigation decisions taken by the Competition Board are announced to the public after the decision is notified to the undertakings or associations of undertakings about which an investigation has been initiated. Those announcements are made within the framework of informing the public about the decisions of the Competition Board and cannot be interpreted to mean that the undertakings or associations of undertakings under investigation violated the Act no 4054, or they are or will be subject to penal sanctions under the Act.